We are proud to showcase Curing Corporate Short-Termism by Fortuna Advisors’ CEO, Greg Milano. The book is an inside look at the ideas and applications that underpin much of Fortuna’s unique client work.
ABOUT
Curing Corporate Short-Termism is a guide for senior managers who want to encourage more investment in the future of their companies, all while maintaining discipline around profitability and capital productivity.

Many corporate practices create stiff headwinds for managers trying to grow their business. The book explores the process of developing a “culture of ownership” that overcomes these obstacles, including prescriptive methods on how to better set goals, develop plans, allocate resources, approve investments, make operating decisions, measure performance, and design better incentive compensation.



Companies that embrace these principles produce long-term value that benefits not just the organization’s shareholders, but all of its many stakeholders, including society at large.

The book is available now for purchase on Amazon.comHardcover and Kindle versions are also available.
ENDORSEMENTS

“An effective playbook for creating sustainable value that benefits all stakeholders”

Claaus Aagaard, Chief Financial Officer—Mars, Inc.

“As CEO of the first client to embrace the Fortuna Advisors framework, I can assure readers that their approach really works, and Curing Corporate Short-Termism is an interesting and engaging explanation of why and how to get managers to think more like owners of the company”

Bill Chiles, Board Member—Pelican Energy Partners (former CEO—Bristow Group)

Curing Corporate Short-Termism includes many of the steps we have taken by incorporating Varian Value Added, which is based on Fortuna’s RCE, into our way of bridging strategic planning to operating actions, capital allocation and performance measurement.  This has helped transform our way of doing business.  Our team is now living and breathing this as part of our business management system resulting in investing more in the future while driving current performance.”

Gary E. Bischoping, Jr., Senior Vice President Finance and Chief Financial Officer—Varian Medical Systems

. . . a must-read for executives, investors and boards.  While the book may not eradicate corporate short-termism, it identifies the keys to long-term value creation and debunks the many myths, conventions and biases that stand in its way.”

Scott Ostfeld, Partner and Co-Portfolio Manager—Jana Partners

 “ . . . a thought-provoking book. This goes well beyond synthesizing the key elements of shareholder value creation and gets to the nub of the behavioral issues holding back optimal Intrinsic Value Creation.  This will be certain to advance our thinking in corporate finance.”

Paul Clancy, Executive Vice President and Chief Financial Officer—Alexion Pharmaceuticals 

RELATED MEDIA
INQUIRIES

For inquiries related to the book, please reach out to:

info@fortuna-advisors.com

READY TO
Learn More?

Connect with us to discuss your company and
how we can find its catalyst for growth.